ALIMPEarnings•businesswire•
IMPLANET Announces First-Half 2025 Results
Sentiment:Negative (0)
Summary
(ALIMP) BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced its results for the first half of the fiscal year ended June 30, 2025, as approved by the Board of Directors on September 16, 2025. Ludovic Lastennet, IMPLANET’s Chief Executive Officer, stated: "In the first half of 2025,
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 16, 2025 by businesswire